Securitas Bio is an international Venture Studio delivering expertise, funding and strategic guidance for novel & innovative startups focused on transformative treatments, sciences and therapies. They needed a complete branding makeover, investment presentation and the relaunch of one of their flagship companies: VirTech Bio.
RESULTS: RedThread re-branded Securitas Bio and VirTech Bio and delivered a new website, tools, video and investor presentation…they are now finalizing funding for $20M!
Publicly traded Repligen needed to introduce its nascent disposable chromatography column platform—we developed a name, positioning, branding and launched a new campaign, website, conference materials and interactive sales tools. RedThread was the only marketing firm during Repligen’s explosive growth!
RESULTS: OPUS chromatography columns were established as global leader. Repligen’s stock (RGEN) rocketed from $2 to $50+ a share.
4th Dimension Bioprocess, a novel biomanufacturing start-up required a strategy, identity, brand, investor presentation and a vision-shaping website to attract and engage investors and acquisition opportunities.
RESULTS: 5 months after launch 4th Dimension Bioprocess was acquired by Resilience Capital Partners chaired by Robert Nelson and a world class team of investors and scientists.
Tarpon BioSystem wanted to brand and position BioSMB as the leading downstream processing technology and position the company for funding or acquisition.
RESULTS: RedThread developed Tarpon BioSystem’s value proposition and brand, and delivered a new website, collateral materials and strategic presentations. Tarpon BioSystems was acquired by Pall Corporation.
CET offered complex proteins and cell lines for clients around the world, but their value proposition wasn’t clear and outreach efforts didn’t create proper lead generation nor brand awareness. RedThread delivered a new brand, website, outreach platform integrated with HubSpot and new commerce engine along with lead generation campaigns and loyalty initiatives.
RESULTS: CET saw their largest sales secured, growth in product orders and expanded distribution internationally.
Cytosen had developed new NK Cells technology and wanted to raise capital or engage acquisition opportunities from prospective companies & investment firms. They required branding, positioning and materials to meet their objectives.
RESULTS: RedThread delivered new positioning and branding across multiple media platforms. Cytosen was acquired by Kiadis Pharma 4 months later.
